T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy
Authors
Keywords
-
Journal
OncoImmunology
Volume 7, Issue 3, Pages e1382793
Publisher
Informa UK Limited
Online
2017-09-28
DOI
10.1080/2162402x.2017.1382793
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell “missing self” recognition
- (2017) Karl-Johan Malmberg et al. IMMUNOGENETICS
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors
- (2016) Elien M. Doorduijn et al. JOURNAL OF CLINICAL INVESTIGATION
- Preventing tumor escape by targeting a post-proteasomal trimming independent epitope
- (2016) Ana Textor et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015
- (2016) J. Galon et al. Journal of Translational Medicine
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Limited Density of an Antigen Presented by RMA-S Cells Requires B7-1/CD28 Signaling to Enhance T-Cell Immunity at the Effector Phase
- (2014) Xiao-Lin Li et al. PLoS One
- T-cell tolerance in cancer
- (2013) Roza Nurieva et al. Immunotherapy
- New Role of Signal Peptide Peptidase To Liberate C-Terminal Peptides for MHC Class I Presentation
- (2013) C. C. Oliveira et al. JOURNAL OF IMMUNOLOGY
- Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
- (2011) A. Curti et al. BLOOD
- Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires
- (2011) Cláudia C. Oliveira et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection
- (2011) Linda M. Wakim et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More